Insulet recently launched the Omnipod 5 system in Canada, marking a noteworthy advancement in diabetes management with public reimbursement already underway in some provinces. Despite this ...

Insulet experienced a 5% increase in share price over the past week, a period marked by significant financial advancements and product developments. The company's successful closure of $450 ...

Insulet Stock Performance NASDAQ:PODD opened at $250.73 on Thursday. Insulet Co. has a 1 year low of $160.19 and a 1 year high of $289.46. The company has a debt-to-equity ratio of 1.21, a current ...

With a market cap of $18.4 billion, Insulet Corporation (PODD) is a leading developer of innovative insulin delivery systems for people with insulin-dependent diabetes. The company's flagship ...

Shares of Insulet Corp. PODD slipped 1.57% to $246.80 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.13% to 5,282.70 ...

Insulet experienced a 5% increase in share price over the past week, a period marked by significant financial advancements and product developments. The company's successful closure of $450 million in ...

Francis Aruputham, a corporal with the Penang police contingent headquarters in George Town, was found shot in the head on Tuesday. (File pic) The policeman who allegedly shot himself in the head ...

Shares of Insulet Corp. PODD rose 1.00% to $253.99 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.81% to 5,363.36 and ...

Insulet Corporation PODD has witnessed strong momentum in the past year. Shares of the company have risen 62.9% compared with 9.9% growth of the industry during the same time frame. The S&P 500 ...

As you can see from the chart above the percentage of shares that are sold short for Insulet has declined since its last report. This does not mean that the stock is going to rise in the near-term ...

Businessman Zarul Ahmad Zulkifli says he is ‘thankful’ to former Penang chief minister Lim Guan Eng since his company did not suffer any loss from bidding for the Penang undersea tunnel project.

On the type 1 diabetes front, Insulet Corp.’s RADIANT study demonstrated massive improvement in time in range as well as lower glycemic levels for patients switching from multiple injections to the ...